Setting the research agenda for future clinical trials on the use of biologics in rheumatology.
Alan
A
Silman
Sarah
S
Rudkin
Tom
T
Walley
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001688:Biological Products / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000627:therapeutic use*; D035843:Biomedical Research; D002986:Clinical Trials as Topic; D006801:Humans; D012107:Research Design; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012219:Rheumatology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000187:drug effects
D018501:Antirheumatic Agents; D001688:Biological Products; D014409:Tumor Necrosis Factor-alpha